FDA will more aggressively conduct active safety surveillance to identify early signs of adverse events linked to medical products. FDA will also implement new requirements under the FDA Amendments Act of 2007 related to clinical trials, pediatric drugs and devices, postmarket study commitments, and the labeling and safe use of drugs. FDA will also establish unique device identifiers to track devices, facilitate device recalls, and support inventory management during disasters and the response to terrorism events. Finally, FDA will conduct more import exams and foreign and domestic inspections of medical product manufacturers.
Modernizing FDA Science and Workforce (+$50 million)


The budget amendment also proposes increases to strengthen FDA's capacity to support product safety and development in areas of emerging science such as nanotechnology, cell and gene therapies, robotics, genomics, advanced manufacturing, and the critical path initiative. FDA will also improve laboratories and other facilities that are essential to carrying out FDA's mission and invest in science training, professional development, and fellowship programs to strengthen and modernize the FDA workforce.

The program increases listed above include $65 million to modernize FDA's information technology infrastructure.

Additional information is available online at:

www.importsafety.gov

www.fda.gov

http://www.fda.gov/oc/initiatives/advance/food.html

###

FDA Fact Sheet: Investing in FDA's Transformation

RSS Feed for FDA News Releases [what's this?]

Back to HCB News

More Industry Headlines